BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29628610)

  • 21. Clinical evaluation and options for infrainguinal atherosclerosis therapy: when to intervene?
    Jaff MR
    J Interv Cardiol; 2001 Oct; 14(5):529-32. PubMed ID: 12053644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Octogenarians develop infrapopliteal arterial occlusive disease in the absence of traditional risk factors.
    Hylton JR; Smith CA; Li CS; Pevec WC
    Ann Vasc Surg; 2014 Oct; 28(7):1712-8. PubMed ID: 24858583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.
    Cea-Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
    BMJ Open; 2018 Jan; 8(1):e018184. PubMed ID: 29358428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and pathophysiology of peripheral arterial disease.
    Levy PJ
    Clin Cornerstone; 2002; 4(5):1-15. PubMed ID: 12425180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral artery disease is associated with high in-hospital mortality particularly in males with acute myocardial infarction in a nationwide real-world setting.
    Freisinger E; Malyar NM; Reinecke H
    Vasa; 2016; 45(2):169-74. PubMed ID: 27058804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease.
    Hirsch AT; Duprez D
    Vasc Med; 2003 Nov; 8(4):273-8. PubMed ID: 15125489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.
    Selvin E; Erlinger TP
    Circulation; 2004 Aug; 110(6):738-43. PubMed ID: 15262830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.
    Kobayashi T; Parikh SA; Giri J
    Curr Cardiol Rep; 2015 Oct; 17(10):86. PubMed ID: 26280273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and Outcomes.
    Srivaratharajah K; Abramson BL
    Can J Cardiol; 2018 Apr; 34(4):356-361. PubMed ID: 29571419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Trends in Endovascular and Surgical Treatment of Peripheral Arterial Disease in the Medicare Population.
    Guez D; Hansberry DR; Gonsalves CF; Eschelman DJ; Parker L; Rao VM; Levin DC
    AJR Am J Roentgenol; 2020 May; 214(5):962-966. PubMed ID: 32097027
    [No Abstract]   [Full Text] [Related]  

  • 31. Nutrition impacts the prevalence of peripheral arterial disease in the United States.
    Lane JS; Magno CP; Lane KT; Chan T; Hoyt DB; Greenfield S
    J Vasc Surg; 2008 Oct; 48(4):897-904. PubMed ID: 18586439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging drugs in peripheral arterial disease.
    Tulsyan N; Ouriel K; Kashyap VS
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral artery disease patients may benefit more from aggressive secondary prevention than aneurysm patients to improve survival.
    Ultee KHJ; Hoeks SE; Gonçalves FB; Boersma E; Stolker RJ; Verhagen HJM; Rouwet EV
    Atherosclerosis; 2016 Sep; 252():147-152. PubMed ID: 27544931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk of peripheral arterial disease in patients with alcohol intoxication: A population-based retrospective cohort study.
    Huang JY; Chen WK; Lin CL; Lai CY; Kao CH; Yang TY
    Alcohol; 2017 Dec; 65():25-30. PubMed ID: 29084626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
    Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
    Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation Dosage for Percutaneous PAD Treatment is Different in Cardiovascular Disciplines: Results From an Eleven Year Population Based Registry in the Metropolitan Area of Hamburg.
    Behrendt CA; Rieß HC; Heidemann F; Diener H; Rohlffs F; Hohnhold R; Debus ES
    Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):215-222. PubMed ID: 27974252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Financial barriers in accessing medical care for peripheral artery disease are associated with delay of presentation and adverse health status outcomes in the United States.
    Jelani QU; Jhamnani S; Spatz ES; Spertus J; Smolderen KG; Wang J; Desai NR; Jones P; Gosch K; Shah S; Attaran R; Mena-Hurtado C
    Vasc Med; 2020 Feb; 25(1):13-24. PubMed ID: 31603393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral Arterial Disease in Sub-Saharan Africa: A Review.
    Johnston LE; Stewart BT; Yangni-Angate H; Veller M; Upchurch GR; Gyedu A; Kushner AL
    JAMA Surg; 2016 Jun; 151(6):564-72. PubMed ID: 27050676
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.